Enhanced anti-tumour effects of Vinca alkaloids given separately from cytostatic therapies

NOXA as critical mediator for drug combinations in polychemotherapy

(2012) H Ehrhardt et al.   Cell Death & Disease

Optimized anti-tumor effects of anthracyclines plus Vinca alkaloids using a novel, mechanism-based application schedule

(2011) H. Ehrhardt et al.   BLOOD

It's all in the timing

(2011) L. J. Bendall   BLOOD

Important Role of Caspase-8 for Chemosensitivity of ALL Cells

(2011) H. Ehrhardt et al.   CLINICAL CANCER RESEARCH

Recent Advances in p53 Research and Cancer Treatment

(2011) Kazufumi Suzuki et al.   JOURNAL OF BIOMEDICINE AND BIOTECHNOLOGY

Guidelines for reporting experiments involving animals: the ARRIVE guidelines

(2010) JC McGrath et al.   BRITISH JOURNAL OF PHARMACOLOGY

Animal research: Reporting in vivo experiments: The ARRIVE guidelines

(2010) Carol Kilkenny et al.   BRITISH JOURNAL OF PHARMACOLOGY

Systemic cancer therapy: Evolution over the last 60 years

(2010) Grace K. Dy et al.   CANCER

Therapy-Induced Senescence in Cancer

(2010) Jonathan A. Ewald et al.   JNCI-Journal of the National Cancer Institute

Specific lentiviral shRNA-mediated knockdown of cyclin D1 in mantle cell lymphoma has minimal effects on cell survival and reveals a regulatory circuit with cyclin D2

(2008) M Klier et al.   LEUKEMIA